台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    22.50
  • 漲跌
    ▲0.15
  • 漲幅
    +0.67%
  • 成交量
    377
  • 產業
    上市 生技醫療類股▼0.22%
  • 299人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
神隆 (1789)籌碼相關-永豐金-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20122.1500.0022.2513880.26%
2025/01/1700.00122.4522.35-1394-0.25%
2025/01/16122.0500.0022.2013950.25%
2025/01/15022.1000.0022.1003940.01%
2025/01/13122.1500.0022.2513900.26%
2025/01/0900.00122.5522.60-1371-0.27%
2025/01/0600.000.522.3022.20-0.5362-0.12%
2024/12/2600.00122.7022.55-1366-0.27%
2024/12/13222.4000.0022.2023510.57%
2024/12/12122.9000.0022.7013410.29%
2024/12/11222.9500.0022.8523380.59%
2024/12/06123.4500.0023.5513400.29%
2024/12/05123.5500.0023.5013440.29%
2024/12/0400.00123.9523.95-1350-0.29%
2024/11/29123.2000.0023.4013650.27%
2024/11/20123.6000.0023.6013740.27%
2024/11/15223.1500.0023.0523750.53%
2024/11/1200.002023.4523.30-20371-5.39%
2024/11/06123.8000.0023.5513600.28%
2024/11/040.124.1000.0024.050.13650.02%
2024/10/24124.2000.0024.2014050.25%
2024/10/23124.3000.0024.3514060.25%
2024/10/220.124.6500.0024.500.14080.02%
2024/10/161.124.55124.5524.400.14620.01%
2024/10/08224.8300.0024.8525280.38%
2024/10/07224.9300.0025.0025360.37%
2024/10/04125.0500.0025.0515480.18%
2024/10/0100.00125.6025.50-1555-0.18%
2024/09/3000.00125.7025.70-1569-0.18%
2024/09/26125.4500.0025.2515960.17%
2024/09/2500.00125.5525.55-1621-0.16%
2024/09/2400.00125.2525.30-1635-0.16%
2024/09/2000.00125.1525.15-1663-0.15%
2024/09/18124.6500.0024.6016710.15%
2024/09/1200.00224.6024.65-2703-0.28%
2024/09/11224.2000.0024.2027120.28%
2024/09/09123.80124.5024.5007430.00%
2024/09/04224.7000.0024.2528050.25%
2024/08/3000.00125.7525.75-1832-0.12%
2024/08/29125.35125.4525.5508540.00%
2024/08/21225.4000.0025.3528950.22%
2024/08/15125.2000.0025.2011,0030.10%
2024/08/071025.0000.0025.10101,1100.90%
2024/08/0510.124.4500.0023.9510.11,1080.91%
2024/08/02026.1500.0025.7501,0960.00%
2024/07/26126.0500.0026.0511,1310.09%
2024/07/15127.2000.0027.2011,2110.08%
2024/07/10128.2500.0028.0511,2080.08%
2024/07/0800.00429.2829.05-41,220-0.33%
2024/07/0500.00328.9028.90-31,239-0.24%
2024/07/03328.9500.0028.9031,3010.23%
2024/07/0100.001.129.6329.45-1.11,343-0.08%
2024/06/2600.00129.1529.10-11,371-0.07%
2024/06/11129.1500.0029.2011,5380.06%
2024/06/0700.00029.0028.8501,5080.00%
2024/06/0400.00228.8528.90-21,512-0.13%
2024/05/2200.00129.0028.65-11,476-0.07%
2024/05/21129.701729.4329.35-161,453-1.10%
2024/05/20229.234.329.1829.35-2.31,387-0.16%
2024/05/1700.00428.3828.60-41,341-0.30%
2024/05/16327.90127.9528.1021,3180.15%
2024/05/15127.75127.8527.8501,3080.00%
2024/05/130.127.7500.0027.600.11,3060.00%
2024/05/0800.00128.0027.90-11,299-0.08%
2024/04/29128.75329.0729.10-21,228-0.16%
2024/04/2600.00228.2528.15-21,176-0.17%
2024/04/25028.150.128.0728.20-0.11,1580.00%
2024/04/2400.000.127.9527.95-0.11,158-0.01%
2024/04/2300.002.227.8328.00-2.21,161-0.19%
2024/04/220.127.30127.3027.45-0.91,154-0.08%
2024/04/19226.9300.0026.7521,1470.17%
2024/04/18127.3500.0027.6511,1280.09%
2024/04/1700.00127.6527.75-11,126-0.09%
2024/04/16227.05127.4026.9511,1180.09%
2024/04/15127.5000.0027.4511,1110.09%
2024/04/1100.00928.6028.05-91,069-0.84%
2024/04/10528.702828.3628.70-231,040-2.21%
2024/04/09427.81128.1027.8039850.30%
2024/04/0800.00128.3528.30-1962-0.10%
2024/04/03427.44227.7527.7529190.22%
2024/04/021127.6500.0027.60118941.23%
2024/04/01127.4500.0027.4518850.11%
2024/03/29127.850.127.7027.650.98760.11%
2024/03/28127.55527.7927.65-4821-0.49%
2024/03/25126.6000.0026.3516850.15%
2024/03/22026.3500.0026.5006790.00%
2024/03/20326.57426.6926.70-1661-0.15%
2024/03/180.125.452525.5925.40-25607-4.11%
2024/03/151.125.70126.0526.100.15890.01%
2024/03/14926.001025.8926.00-1580-0.17%
2024/03/13525.50525.6025.6505740.00%
2024/03/1200.00125.6525.60-1576-0.17%
2024/03/1146.125.16225.2825.3544.15717.70%
2024/03/082.125.0500.0024.502.15600.38%
2024/03/07325.1200.0025.1035660.53%
2024/02/230.125.0000.0025.150.16080.01%
2024/02/22325.4000.0025.4536030.50%
2024/02/160.125.5000.0025.550.16140.01%
漢達私募引進神隆成第二大股東 攜手拓展改良型新藥Anue鉅亨-2024/12/20
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
神隆 相關文章